Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.

Por Davey, R T, Chaitt, D G, Reed, G F, Freimuth, W W, Herpin, B R, Metcalf, J A, Eastman, P S, Falloon, J, Kovacs, J A, Polis, M A, Walker, R E, Masur, H, Boyle, J, Coleman, S, Cox, S R, Wathen, L, Daenzer, C L, Lane, H C
Publicado em 1996